Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Platinum Resistant Ovarian Cancer Recruiting

2024-514822-21-00 Platinum-resistant Ovarian Cancer 5 2025-10-02
Randomized double blind phase 2 trial of baby exemestane versus baby tamoxifen in postmenopausal women at high risk for breast cancer Recruiting

2024-520004-26-00 Breast cancer 4 2025-10-01
A Randomized, Open-Label, Controlled Phase 3 Study Comparing Daratumumab, Lenalidomide and Dexamethasone Induction followed by Linvoseltamab… Recruiting

2024-519827-16-00 Newly Diagnosed Transplant Ineligible Multiple Myeloma 5 2025-09-30
Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Recruiting

2023-509861-19-01 High-grade B-cell lymphoma (HGBL) 4 2025-09-30
A short-term preoperative, window-of-opportunity study, evaluating activity and safety of Elacestrant monotherapy as compared to Elacestrant… Recruiting

2024-520051-24-00 Breast cancer 4 2025-09-30
Regorafenib as second-line treatment of patients with RAS-mutant advanced colorectal cancer: a multicentre, phase 2 study - STREAM-2 Recruiting

2024-519669-23-00 Patients with metastatic colorectal cancer (mCRC) RAS-m 4 2025-09-29
INTERACT stomach-II Recruiting

2025-521468-36-00 Gastric peritoneal metastases 4 2025-09-29
Using lab-grown mini-tumors from pancreatic cancer tissue to predict and improve post-surgery treatment for pancreatic cancer Recruiting

2023-510490-34-00 Patients with functionally resectable pancreatic ductal 4 2025-09-29
A clinical study of MK-1084 with targeted therapy and chemotherapy in people with colorectal cancer (MK-1084-012). Recruiting

2024-517232-22-00 KRAS G12C-mutant, Locally Advanced Unresectable or Meta 5 2025-09-26
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen Recruiting

2024-519875-24-00 Carcinoid syndrome 5 2025-09-26
INTER-EWING-1: International Clinical Research Programme to Improve Outcomes in Newly Diagnosed Ewing Sarcoma – Trial 1 Recruiting

2024-511989-36-00 Ewing Sarcoma 5 2025-09-24
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutec… Recruiting

2024-518015-19-00 Colorectal Cancer 4 2025-09-24
ISEE-RCC study Recruiting

2024-514181-39-00 Metastatic renal cell carcinoma 5 2025-09-23
A Phase 3 study of NBTXR3 with or without cetuximab in LA-HNSCC Recruiting

2024-520386-31-00 Locally Advanced Head & Neck Squamous Cell Carcinoma 5 2025-09-22
HER2-Targeting Site-Specific Labelled 89Zr-Trastuzumab PET Imaging of Patients with Cancer Recruiting

2024-516786-37-00 Patients with breast cancer, gastroesophageal adenocarc 1 2025-09-22
Trial of an investigational drug after the rejection of an allogeneic transplant. Recruiting

2022-503063-15-00 Multiple myeloma. 7 2025-09-22
Towards improved therapy selection and targeted treatment for nasopharyngeal carcinoma. A proof-of-concept pilot study for somatostatin rece… Recruiting

2025-520689-23-00 nasopharyngeal carcinoma 9 2025-09-22
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Compared to Oral Lenvatinib Capsul… Recruiting

2024-518012-39-00 Squamous-Cell Non-Small Cell Lung Cancer 1 2025-09-22
Safety and preliminary efficacy of pumitamig (BNT327), an investigational therapy for patients with non-small cell lung cancer in combinatio… Recruiting

2024-518279-80-00 Non-small Cell Lung Cancer 4 2025-09-19
Cemiplimab maintenance treatment for advanced adrenocortical cancer Recruiting

2024-520449-21-00 Adrenocortical carcinoma 4 2025-09-18
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-line Treatment of PD-L1-high Metastatic Non-small Cell Lung… Recruiting

2024-517780-24-00 Lung Cancer 5 2025-09-18
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination with Osimertinib as Firs… Recruiting

2024-518586-10-00 Non-Squamous Non-Small Cell Lung Cancer 10 2025-09-18
A Phase 1 study of GSK5764227 in participants with advanced solid tumors Recruiting

2024-513663-10-01 Neoplasms 3 2025-09-17
CATALINA-2: A Phase 2 Study of TORL-1-23 in Advanced Ovarian Cancer Recruiting

2024-517190-24-00 Peritoneal Cancer 4 2025-09-16